1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global mRNA Vaccines & Therapeutics Consumption 2016-2026
2.1.2 mRNA Vaccines & Therapeutics Consumption CAGR by Region
2.2 mRNA Vaccines & Therapeutics Segment by Type
2.2.1 Infectious Disease Vaccines
2.2.2 Cancer Vaccines
2.3 mRNA Vaccines & Therapeutics Sales by Type
2.3.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021)
2.3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2016-2021)
2.3.3 Global mRNA Vaccines & Therapeutics Sale Price by Type (2016-2021)
2.4 mRNA Vaccines & Therapeutics Segment by Application
2.4.1 Infectious Disease
2.4.2 Cancer
2.5 mRNA Vaccines & Therapeutics Sales by Application
2.5.1 Global mRNA Vaccines & Therapeutics Sale Market Share by Application (2016-2021)
2.5.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Application (2016-2021)
2.5.3 Global mRNA Vaccines & Therapeutics Sale Price by Application (2016-2021)
3 Global mRNA Vaccines & Therapeutics by Company
3.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Company
3.1.1 Global mRNA Vaccines & Therapeutics Sales by Company (2019-2021)
3.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Company (2019-2021)
3.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Company
3.2.1 Global mRNA Vaccines & Therapeutics Revenue by Company (2019-2021)
3.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Company (2019-2021)
3.3 Global mRNA Vaccines & Therapeutics Sale Price by Company
3.4 Global Manufacturers mRNA Vaccines & Therapeutics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers mRNA Vaccines & Therapeutics Product Location Distribution
3.4.2 Players mRNA Vaccines & Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 mRNA Vaccines & Therapeutics by Region
4.1 Global mRNA Vaccines & Therapeutics by Region
4.1.1 Global mRNA Vaccines & Therapeutics Sales by Region
4.1.2 Global mRNA Vaccines & Therapeutics Revenue by Region
4.2 Americas mRNA Vaccines & Therapeutics Sales Growth
4.3 APAC mRNA Vaccines & Therapeutics Sales Growth
4.4 Europe mRNA Vaccines & Therapeutics Sales Growth
4.5 Middle East & Africa mRNA Vaccines & Therapeutics Sales Growth
5 Americas
5.1 Americas mRNA Vaccines & Therapeutics Sales by Country
5.1.1 Americas mRNA Vaccines & Therapeutics Sales by Country (2016-2021)
5.1.2 Americas mRNA Vaccines & Therapeutics Revenue by Country (2016-2021)
5.2 Americas mRNA Vaccines & Therapeutics Sales by Type
5.3 Americas mRNA Vaccines & Therapeutics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Vaccines & Therapeutics Sales by Region
6.1.1 APAC mRNA Vaccines & Therapeutics Sales by Region (2016-2021)
6.1.2 APAC mRNA Vaccines & Therapeutics Revenue by Region (2016-2021)
6.2 APAC mRNA Vaccines & Therapeutics Sales by Type
6.3 APAC mRNA Vaccines & Therapeutics Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe mRNA Vaccines & Therapeutics by Country
7.1.1 Europe mRNA Vaccines & Therapeutics Sales by Country (2016-2021)
7.1.2 Europe mRNA Vaccines & Therapeutics Revenue by Country (2016-2021)
7.2 Europe mRNA Vaccines & Therapeutics Sales by Type
7.3 Europe mRNA Vaccines & Therapeutics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa mRNA Vaccines & Therapeutics by Country
8.1.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2016-2021)
8.1.2 Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2016-2021)
8.2 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type
8.3 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 mRNA Vaccines & Therapeutics Distributors
10.3 mRNA Vaccines & Therapeutics Customer
11 Global mRNA Vaccines & Therapeutics Market Forecast
11.1 Global mRNA Vaccines & Therapeutics Forecast by Region
11.1.1 Global mRNA Vaccines & Therapeutics Forecast by Regions (2021-2026)
11.2.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global mRNA Vaccines & Therapeutics Forecast by Type
11.7 Global mRNA Vaccines & Therapeutics Forecast by Application
12 Key Players Analysis
12.1 Moderna Therapeutics
12.1.1 Moderna Therapeutics Company Information
12.1.2 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Offered
12.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Moderna Therapeutics Main Business Overview
12.1.5 Moderna Therapeutics Latest Developments
12.2 CureVac
12.2.1 CureVac Company Information
12.2.2 CureVac mRNA Vaccines & Therapeutics Product Offered
12.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 CureVac Main Business Overview
12.2.5 CureVac Latest Developments
12.3 Translate Bio
12.3.1 Translate Bio Company Information
12.3.2 Translate Bio mRNA Vaccines & Therapeutics Product Offered
12.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Translate Bio Main Business Overview
12.3.5 Translate Bio Latest Developments
12.4 BioNTech
12.4.1 BioNTech Company Information
12.4.2 BioNTech mRNA Vaccines & Therapeutics Product Offered
12.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 BioNTech Main Business Overview
12.4.5 BioNTech Latest Developments
12.5 Sangamo Therapeutics
12.5.1 Sangamo Therapeutics Company Information
12.5.2 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Offered
12.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Sangamo Therapeutics Main Business Overview
12.5.5 Sangamo Therapeutics Latest Developments
12.6 Argos Therapeutics
12.6.1 Argos Therapeutics Company Information
12.6.2 Argos Therapeutics mRNA Vaccines & Therapeutics Product Offered
12.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Argos Therapeutics Main Business Overview
12.6.5 Argos Therapeutics Latest Developments
12.7 In-Cell-Art
12.7.1 In-Cell-Art Company Information
12.7.2 In-Cell-Art mRNA Vaccines & Therapeutics Product Offered
12.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 In-Cell-Art Main Business Overview
12.7.5 In-Cell-Art Latest Developments
12.8 eTheRNA
12.8.1 eTheRNA Company Information
12.8.2 eTheRNA mRNA Vaccines & Therapeutics Product Offered
12.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 eTheRNA Main Business Overview
12.8.5 eTheRNA Latest Developments
12.9 Ethris
12.9.1 Ethris Company Information
12.9.2 Ethris mRNA Vaccines & Therapeutics Product Offered
12.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Ethris Main Business Overview
12.9.5 Ethris Latest Developments
12.10 Tiba Biotechnology
12.10.1 Tiba Biotechnology Company Information
12.10.2 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Offered
12.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Tiba Biotechnology Main Business Overview
12.10.5 Tiba Biotechnology Latest Developments
13 Research Findings and Conclusion
